Advertisement
Screener

Citius Pharmaceuticals, Inc. (CTXR) Cost of Goods and Services Sold

1.7 / 5 stars · 18/54 Roast Me

Citius Pharmaceuticals, Inc. Cost of Goods and Services Sold

Citius Pharmaceuticals, Inc. (CTXR) reported Cost of Goods and Services Sold of $75.00 thousand for the 12-month period ending 2018-09-30, per its 10-K filed 2019-12-16.

Discontinued › Expense Statement

us-gaap:CostOfGoodsAndServicesSold · last filed 2019-12-16

  • Citius Pharmaceuticals, Inc. cost of goods and services sold for fiscal 2018 was $75.00K, a 50.00% increase from fiscal 2017.
  • Citius Pharmaceuticals, Inc. cost of goods and services sold for fiscal 2017 was $50.00K, a 11.11% increase from fiscal 2016.
  • Citius Pharmaceuticals, Inc. cost of goods and services sold for fiscal 2016 was $45.00K.
Period endCost of Goods and Services Sold 12 month
2018-09-30$75.00K
10-K · filed 2019-12-16
2017-09-30$50.00K
10-K · filed 2019-12-16
2016-09-30$45.00K
10-K · filed 2019-12-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36